GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » Total Receivables

Artrya (ASX:AYA) Total Receivables : A$2.26 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Artrya Total Receivables?

Artrya's Total Receivables for the quarter that ended in Dec. 2023 was A$2.26 Mil.


Artrya Total Receivables Historical Data

The historical data trend for Artrya's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artrya Total Receivables Chart

Artrya Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Total Receivables
1.43 1.99 3.07 3.87

Artrya Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Receivables Get a 7-Day Free Trial 1.99 3.45 3.07 2.26 3.87

Artrya Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Artrya Total Receivables Related Terms

Thank you for viewing the detailed overview of Artrya's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Artrya Business Description

Traded in Other Exchanges
N/A
Address
1257 Hay Street, West Perth, WA, AUS, 6005
Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.

Artrya Headlines

No Headlines